Genmab A/s Earnings

Genmab A/s’s revenue jumped 37.69% since last year same period to $6441Mn in the Q4 2024. On a quarterly growth basis, Genmab A/s has generated 16.26% jump in its revenue since last 3-months.

Genmab A/s’s net profit jumped 500.78% since last year same period to $3845Mn in the Q4 2024. On a quarterly growth basis, Genmab A/s has generated 203.71% jump in its net profits since last 3-months.

Genmab A/s’s net profit margin jumped 336.34% since last year same period to 59.7% in the Q4 2024. On a quarterly growth basis, Genmab A/s has generated 161.23% jump in its net profit margins since last 3-months.

Genmab A/s’s earning per share (EPS) estimates for the current quarter stand at 0.36 - a 2.43% jump from last quarter’s estimates.

Genmab A/s’s earning per share (EPS) estimates for the current year stand at 0.36.

Genmab A/s’s earning per share (EPS) jumped 496.5% since last year same period to 0.84 in the Q4 2024. This indicates that the Genmab A/s has generated 496.5% annual rate of jump in its earning per share (EPS) in the last 4 quarters.